https://www.selleckchem.com/products/pomhex.html
rs in the head and neck. Itching is the most frequent pathology in dermatology that has significant impacts on people's mental health and social life. Transient receptor potential vanilloid 3 (TRPV3) channel is a promising target for treating pruritus. However, few selecetive and potent antagonists have been reported. This study was designed to identify selective TRPV3 antagonist and elucidate its anti-pruritus pharmacology. FlexStation and calcium fluorescence imaging were conducted to track the functional compounds. Whole-cell patch cl
Aimer
Commentaire
Partagez
